Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 2,880.00
-5.00 (-0.17%)
At close: Feb 6, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 223.93 billion as of February 6, 2026. Its market cap has decreased by -42.27% in one year.
Market Cap
223.93B
Enterprise Value
312.27B
Revenue
13.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,880.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 223.93B, a decrease of -63.49%. That is a compound annual growth rate of -18.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 223.93B | -5.11% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 306.79B |
| Genome & Company | 292.36B |
| curacle co.,ltd. | 260.93B |
| Vaxcell-Bio Therapeutics | 220.71B |
| ISU Abxis | 215.43B |
| Kangstem Biotech | 196.57B |
| QuadMedicine | 187.36B |
| Bio Solution | 181.29B |